Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takako Inoue

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Molecular and Clinical Oncology|July 8, 2017
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancerMadoka Kimura, Fumio Imamura, Takako Inoue, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Thoracic Cancer|September 17, 2025
Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Therapy in Patients With Genetic Alterations in Non-Small Cell Lung CancerTsunehiro Tanaka, Motohiro Tamiya, Akito Miyazaki, et al.
Thoracic Cancer|March 29, 2026
Delayed Tumor Shrinkage Beyond Progressive Disease in Small-Cell Lung Cancer Receiving Immunochemotherapy: A Case ReportTakahisa Kawamura, Kiyohide Komuta, Shun Futamura, et al.
Journal of Hepatology|March 25, 2021
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Shigeru Kusumoto, Etsuko Iio, et al.
Journal of Medical Virology|July 17, 2024
Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B PatientsTakanori Suzuki, Kentaro Matsuura, Takako Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusTakako Inoue, Takaaki Goto, Etsuko Iio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2010
Primary pulmonary T-cell lymphoma in a human T-lymphotropic virus type-1 carrier showing atypical shadowShojiro Minomo, Takayuki Takimoto, Osamu Morimura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Analysis of ERBB ligand-induced resistance mechanism to crizotinib by primary culture of lung adenocarcinoma with EML4-ALK fusion geneMadoka Kimura, Hiroko Endo, Takako Inoue, et al.
Cancer Medicine|June 26, 2024
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulantsTasuku Nakabori, Kei Kunimasa, Masaki Kawabata, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Molecular and Clinical Oncology|July 8, 2017
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancerMadoka Kimura, Fumio Imamura, Takako Inoue, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Thoracic Cancer|September 17, 2025
Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Therapy in Patients With Genetic Alterations in Non-Small Cell Lung CancerTsunehiro Tanaka, Motohiro Tamiya, Akito Miyazaki, et al.
Thoracic Cancer|March 29, 2026
Delayed Tumor Shrinkage Beyond Progressive Disease in Small-Cell Lung Cancer Receiving Immunochemotherapy: A Case ReportTakahisa Kawamura, Kiyohide Komuta, Shun Futamura, et al.
Journal of Hepatology|March 25, 2021
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Shigeru Kusumoto, Etsuko Iio, et al.
Journal of Medical Virology|July 17, 2024
Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B PatientsTakanori Suzuki, Kentaro Matsuura, Takako Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusTakako Inoue, Takaaki Goto, Etsuko Iio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2010
Primary pulmonary T-cell lymphoma in a human T-lymphotropic virus type-1 carrier showing atypical shadowShojiro Minomo, Takayuki Takimoto, Osamu Morimura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Analysis of ERBB ligand-induced resistance mechanism to crizotinib by primary culture of lung adenocarcinoma with EML4-ALK fusion geneMadoka Kimura, Hiroko Endo, Takako Inoue, et al.
Cancer Medicine|June 26, 2024
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulantsTasuku Nakabori, Kei Kunimasa, Masaki Kawabata, et al.
Pageof 15